| 3 | Initial statement of beneficial ownershi... | Hillhouse Investment Management, Ltd. | Schulte Roth & Zabel Llp /fa | 01/25/2024 | |
| 3 | Initial statement of beneficial ownershi... | Arrivent Biopharma, Inc. | Schulte Roth & Zabel Llp /fa | 01/25/2024 | |
| 4 | Statement of changes in beneficial owner... | Enfusion, Inc. | Schulte Roth & Zabel Llp /fa | 10/27/2021 | |
| 4 | Statement of changes in beneficial owner... | Hillhouse Investment Management, Ltd. | Schulte Roth & Zabel Llp /fa | 10/27/2021 | |
| 3 | Initial statement of beneficial ownershi... | Enfusion, Inc. | Schulte Roth & Zabel Llp /fa | 10/21/2021 | |
| 3 | Initial statement of beneficial ownershi... | Hillhouse Investment Management, Ltd. | Schulte Roth & Zabel Llp /fa | 10/21/2021 | |
| 3 | Initial statement of beneficial ownershi... | Beigene, Ltd. | Schulte Roth & Zabel Llp /fa | 02/01/2018 | |
| 3 | Initial statement of beneficial ownershi... | Hillhouse Investment Management, Ltd. | Schulte Roth & Zabel Llp /fa | 02/01/2018 | |
| 4 | Statement of changes in beneficial owner... | Apellis Pharmaceuticals, Inc. | Schulte Roth & Zabel Llp /fa | 11/15/2017 | |
| 4 | Statement of changes in beneficial owner... | Hillhouse Investment Management, Ltd. | Schulte Roth & Zabel Llp /fa | 11/15/2017 | |
| Load More |